{"name":"PrimeVax Immuno-Oncology Inc.","slug":"primevax-immuno-oncology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMzJSblF1T1FxM3FPcXIyZ3JkTE1YX3lrRlpnR29wM2NNYmtnREtYVDRaZk53Yzl1UV9BUDVxZ1ljVkpBb184Q1I0SG9nbTJmclJyV2dXekQzd2NsMzhXTzNMSzUzSTIwTjUxYzVDdGdtV0l6NFJydTlZTFNIejF1MjJNbmtqTkJ6Vm5DNnd6YzJSQ01kSjB0MzlB?oc=5","date":"2025-04-25","type":"earnings","source":"openPR.com","summary":"PD-1 and PD-L1 Inhibitors Market Report- Expansive Coverage on the Profit Sources - openPR.com","headline":"PD-1 and PD-L1 Inhibitors Market Report- Expansive Coverage on the Profit Sources","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}